Literature DB >> 16428453

Receptor activator of NF-kappaB ligand regulates the proliferation of mammary epithelial cells via Id2.

Nam-Shik Kim1, Hyun-Ju Kim, Bon-Kyoung Koo, Min-Chul Kwon, Young-Woong Kim, Yunje Cho, Yoshifumi Yokota, Josef M Penninger, Young-Yun Kong.   

Abstract

Receptor activator of NF-kappaB ligand (RANKL) is a key regulator for mammary gland development during pregnancy. RANKL-deficient mice display impaired development of lobulo-alveolar mammary structures. Similar mammary gland defects have been reported in mice lacking Id2. Here we report that RANKL induces the proliferation of mammary epithelial cells via Id2. RANKL triggers marked nuclear translocation of Id2 in mammary epithelial cells. In vivo studies further demonstrated the defective nuclear translocation of Id2, but the normal expression of cyclin D1, in the mammary epithelial cells of rankl-/- mice. In vitro studies with nuclear localization sequence-tagged Id2 revealed that the nuclear localization of Id2 itself is critical for the downregulation of p21 promoter activity. Moreover, RANKL stimulation failed to induce cell growth and to downregulate p21 expression in Id2-/- mammary epithelial cells. Our results indicate that the inhibitor of helix-loop-helix protein, Id2, is critical to control the proliferation of mammary epithelial cells in response to RANKL stimulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16428453      PMCID: PMC1347028          DOI: 10.1128/MCB.26.3.1002-1013.2006

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  43 in total

1.  Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2.

Authors:  Y Yokota; A Mansouri; S Mori; S Sugawara; S Adachi; S Nishikawa; P Gruss
Journal:  Nature       Date:  1999-02-25       Impact factor: 49.962

2.  Forced expression of cyclin D1 does not compensate for Id2 deficiency in the mammary gland.

Authors:  Seiichi Mori; Kenji Inoshima; Yoko Shima; Emmett V Schmidt; Yoshifumi Yokota
Journal:  FEBS Lett       Date:  2003-09-11       Impact factor: 4.124

3.  IGF-2 is a mediator of prolactin-induced morphogenesis in the breast.

Authors:  Cathrin Brisken; Ayyakkannu Ayyannan; Cuc Nguyen; Anna Heineman; Ferenc Reinhardt; Jian Tan; S K Dey; G Paolo Dotto; Robert A Weinberg; Tian Jan
Journal:  Dev Cell       Date:  2002-12       Impact factor: 12.270

Review 4.  Stromal effects on mammary gland development and breast cancer.

Authors:  Bryony S Wiseman; Zena Werb
Journal:  Science       Date:  2002-05-10       Impact factor: 47.728

5.  IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development.

Authors:  Y Cao; G Bonizzi; T N Seagroves; F R Greten; R Johnson; E V Schmidt; M Karin
Journal:  Cell       Date:  2001-12-14       Impact factor: 41.582

6.  Osteoprotegerin ligand induces beta-casein gene expression through the transcription factor CCAAT/enhancer-binding protein beta.

Authors:  Hyun-Ju Kim; Mi-Jeong Yoon; Jinie Lee; Josef M Penninger; Young-Yun Kong
Journal:  J Biol Chem       Date:  2001-11-28       Impact factor: 5.157

7.  Id2 is critical for cellular proliferation and is the oncogenic effector of N-myc in human neuroblastoma.

Authors:  Anna Lasorella; Renata Boldrini; Carlo Dominici; Alberto Donfrancesco; Yoshifumi Yokota; Alessandro Inserra; Antonio Iavarone
Journal:  Cancer Res       Date:  2002-01-01       Impact factor: 12.701

8.  Mammary epithelial cells are not able to undergo pregnancy-dependent differentiation in the absence of the helix-loop-helix inhibitor Id2.

Authors:  Keiko Miyoshi; Barbara Meyer; Peter Gruss; Yongzhi Cui; Jean-Pierre Renou; Fanta V Morgan; Gilbert H Smith; Moshe Reichenstein; Moshe Shani; Lothar Hennighausen; Gertraud W Robinson
Journal:  Mol Endocrinol       Date:  2002-12

9.  Contribution of the helix-loop-helix factor Id2 to regulation of vascular smooth muscle cell proliferation.

Authors:  Martin E Matsumura; David R Lobe; Coleen A McNamara
Journal:  J Biol Chem       Date:  2001-11-08       Impact factor: 5.157

10.  Regulation of Id2 expression by CCAAT/enhancer binding protein beta.

Authors:  Kazuhiro Karaya; Seiichi Mori; Hisashi Kimoto; Yoko Shima; Yoshihito Tsuji; Hisanori Kurooka; Shizuo Akira; Yoshifumi Yokota
Journal:  Nucleic Acids Res       Date:  2005-04-04       Impact factor: 16.971

View more
  50 in total

Review 1.  Alveolar and lactogenic differentiation.

Authors:  Cathrin Brisken; Renuga Devi Rajaram
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-10       Impact factor: 2.673

2.  Transcriptional response of the murine mammary gland to acute progesterone exposure.

Authors:  Rodrigo Fernandez-Valdivia; Atish Mukherjee; Chad J Creighton; Adam C Buser; Francesco J DeMayo; Dean P Edwards; John P Lydon
Journal:  Endocrinology       Date:  2008-08-07       Impact factor: 4.736

3.  Survival and differentiation of mammary epithelial cells in mammary gland development require nuclear retention of Id2 due to RANK signaling.

Authors:  Nam-Shik Kim; Hyoung-Tai Kim; Min-Chul Kwon; Suk-Won Choi; Yoon-Young Kim; Ki-Jun Yoon; Bon-Kyoung Koo; Myung-Phil Kong; Juhee Shin; Yunje Cho; Young-Yun Kong
Journal:  Mol Cell Biol       Date:  2011-09-26       Impact factor: 4.272

4.  Progesterone receptor and Stat5 signaling cross talk through RANKL in mammary epithelial cells.

Authors:  Alison E Obr; Sandra L Grimm; Kathleen A Bishop; J Wesley Pike; John P Lydon; Dean P Edwards
Journal:  Mol Endocrinol       Date:  2013-09-06

5.  Control of mammary stem cell function by steroid hormone signalling.

Authors:  Marie-Liesse Asselin-Labat; François Vaillant; Julie M Sheridan; Bhupinder Pal; Di Wu; Evan R Simpson; Hisataka Yasuda; Gordon K Smyth; T John Martin; Geoffrey J Lindeman; Jane E Visvader
Journal:  Nature       Date:  2010-04-11       Impact factor: 49.962

Review 6.  RANKL/RANK-beyond bones.

Authors:  Reiko Hanada; Toshikatsu Hanada; Verena Sigl; Daniel Schramek; Josef M Penninger
Journal:  J Mol Med (Berl)       Date:  2011-03-29       Impact factor: 4.599

7.  Strain-specific differences in the mechanisms of progesterone regulation of murine mammary gland development.

Authors:  Mark D Aupperlee; Alexis A Drolet; Srinivasan Durairaj; Weizhong Wang; Richard C Schwartz; Sandra Z Haslam
Journal:  Endocrinology       Date:  2008-11-06       Impact factor: 4.736

8.  Common pathways regulate Type III TGFβ receptor-dependent cell invasion in epicardial and endocardial cells.

Authors:  Cynthia R Clark; Jamille Y Robinson; Nora S Sanchez; Todd A Townsend; Julian A Arrieta; W David Merryman; David Z Trykall; Harold E Olivey; Charles C Hong; Joey V Barnett
Journal:  Cell Signal       Date:  2016-03-10       Impact factor: 4.315

9.  The RANKL/RANK/OPG pathway.

Authors:  Brendan F Boyce; Lianping Xing
Journal:  Curr Osteoporos Rep       Date:  2007-09       Impact factor: 5.096

10.  RANK, RANKL and osteoprotegerin in bone biology and disease.

Authors:  H L Wright; H S McCarthy; J Middleton; M J Marshall
Journal:  Curr Rev Musculoskelet Med       Date:  2009-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.